Table 2. HRs of brain-cancer-specific mortality for all variables.
| Variables | Value (n=38,037) | Brain-cancer-specific mortality (n=8,839) | Unadjusted HR (95% CI) | p | |
|---|---|---|---|---|---|
| Age at brain cancer diagnosis (yr) | 53.33±17.88 | - | 1.04 (1.03–1.04) | <0.001 | |
| Sex | <0.001 | ||||
| Male | 16,791 (44.1) | 4,671 (52.9) | 1.50 (1.44–1.56) | ||
| Female | 21,246 (55.9) | 4,168 (47.2) | 1.00 (reference) | ||
| Sleep disorder | 17,714 (46.6) | 3,995 (45.2) | 0.92 (0.88–0.95) | <0.001 | |
| Zolpidem use | 11,823 (31.1) | 2,827 (32.0) | 1.01 (0.97–1.06) | 0.564 | |
| Depression | 16,030 (42.1) | 3,456 (39.1) | 0.83 (0.79–0.86) | <0.001 | |
| Antidepressant use | 18.573 (48.8) | 3,721 (42.1) | 0.71 (0.68–0.74) | <0.001 | |
Data are n (%) or mean±standard deviation values, except where indicated otherwise.
CI, confidence interval; HR, hazard ratio.